Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

EGX:MPCI Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 1, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	3,504	1,684	505	174	78	150
Market Cap Growth	1629.64%	233.20%	190.25%	123.70%	-48.16%	73.15%
Enterprise Value	2,920	1,090	220	403	-31	123
Last Close Price	154.00	74.03	27.90	9.27	4.14	7.99
PE Ratio	6.93	3.33	2.64	1.93	1.05	3.59
PS Ratio	2.32	1.12	0.58	0.26	0.14	0.29
PB Ratio	4.55	2.19	3.39	1.66	2.13	-3.93
P/TBV Ratio	4.58	2.20	3.60	1.88	3.79	-
P/FCF Ratio	53.37	25.65	3.18	3.75	3.31	107.03
P/OCF Ratio	40.32	19.38	2.76	3.01	2.13	43.26
EV/Sales Ratio	1.94	0.72	0.25	0.61	-	0.24
EV/EBITDA Ratio	5.39	2.01	0.98	3.89	-	2.81
EV/EBIT Ratio	5.59	2.09	1.04	4.21	-	3.61
EV/FCF Ratio	44.47	16.61	1.39	8.67	-	87.71
Debt / Equity Ratio	0.12	0.12	1.19	0.13	0.13	-0.14
Debt / EBITDA Ratio	0.18	0.18	0.79	0.13	0.06	0.12
Debt / FCF Ratio	1.45	1.45	1.12	0.29	0.20	3.82
Asset Turnover	1.11	1.11	0.87	0.99	1.11	1.28
Inventory Turnover	2.34	2.34	2.40	2.29	2.41	2.60
Quick Ratio	1.45	1.45	0.90	0.71	0.39	0.23
Current Ratio	2.15	2.15	1.16	1.03	0.92	0.77
Return on Equity (ROE)	109.89%	109.89%	150.74%	127.74%	-	-
Return on Assets (ROA)	24.09%	24.09%	13.20%	8.91%	8.70%	5.27%
Return on Capital (ROIC)	54.80%	54.80%	59.47%	75.08%	1009.03%	-
Return on Capital Employed (ROCE)	61.90%	61.90%	81.00%	88.10%	180.70%	-
Earnings Yield	14.42%	30.00%	37.88%	51.93%	95.17%	27.84%
FCF Yield	1.87%	3.90%	31.42%	26.70%	30.25%	0.93%
Dividend Yield	2.60%	-	14.34%	21.59%	-	-
Payout Ratio	5.05%	5.05%	6.35%	-	-	0.60%
Buyback Yield / Dilution	-304.44%	-304.44%	-	-	-	-
Total Shareholder Return	-301.85%	-304.44%	14.34%	21.59%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.